Oncology Med, Inc. (ONCO.PK) Executes Second Contract for New Branchytherapy Program
Oncology Med, Inc., a public company engaged in the fulfillment of services related to the treatment of various cancers, announced the execution of a second contract for its new Brachytherapy programs with an ambulatory surgical center located in the Northeastern U.S.. Brachytherapy is the treatment of prostate cancer through the implantation of radioactive seeds. The contract will add $300,000.00 in revenues over the next year, increasing the Company’s run rate by 15% over 12 months. “I’m extremely pleased with the execution of our second contract for our new prostate cancer brachytherapy program,” said Dr. William J. Walker, Chairman of Oncology…